Clementia Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Clementia Pharmaceuticals Ownership

Who owns Clementia Pharmaceuticals?

Clementia Pharmaceuticals is owned by Ipsen SA. It was acquired on February 25, 2019.

Clementia Pharmaceuticals Business Overview

Where is Clementia Pharmaceuticals headquartered?

Clementia Pharmaceuticals is headquartered in Montreal, Quebec.

What sector is Clementia Pharmaceuticals in?

Clementia Pharmaceuticals is a life science company.

When was Clementia Pharmaceuticals founded?

Clementia Pharmaceuticals was founded in 2010.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 245 acquisitions of life science companies in 2019, including 40 acquisitions by private equity firms, and 205 by strategics.

Clementia Pharmaceuticals, Inc.

4150 Sainte-Catherine Street West, Suite 550,
Montreal, Quebec H3Z 2Y5
Canada,
(514) 940-3600
www.clementiapharma.com

Clementia Pharmaceuticals, Inc. is a clinical-stage company innovating treatments for people with ultra-rare bone disorders and other diseases with a high medical need. The company is preparing for a 2019 NDA submission to the FDA to seek approval of its lead product candidate, palovarotene, a novel RARγ agonist, for the prevention of heterotopic ossification (HO) associated with flare-up symptoms in adults and children with fibrodysplasia ossificans progressiva (FOP). Clementia Pharmaceuticals was founded in 2010 and is based in Montreal, Quebec.


 Subscribe to unlock this and 202,187
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 193K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.